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Anti-inﬂammatoryAbstract Seven ﬂavonoidal compounds, apigenin (1), kaempferol-3-O-b-D-glucoside (2),
kaempferol-3-O-a-L-rhamnoside (3), kaempferol-7-methoxy-3-O-a-L-rhamnoside (4), diosmetin-7-
O-b-D-xylosyl-(1000ﬁ600)-b-D-glucopyranoside (5), diosmetin-7-O-a-L-arabinosyl (1000ﬁ600)-b-D-gluco-
pyranoside (6), kaempferol-3-O-a-L-rhamnosyl-(1000ﬁ200)-a-L-rhamnoside (7), in addition to lupeol
(8), b-sitosterol (9) and b-sitosterol-3-O-b-D-glucoside (10) were isolated from the aerial parts of
Carduus pycnocephalus L. The structures of the isolated compounds were established by UV, IR,
FAB-MS, ESI-MS, EI-MS, 1D and 2D NMR spectroscopic methods. Compounds 1, 2, and 4 were
reported for the ﬁrst time from C. pycnocephalus and compounds 5 and 7 were ﬁrst reported from
the genus Carduus. Anti-inﬂammatory, antispasmodic and hypotensive activities were assessed for
all extracts which showed variable activities.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Genus Carduus which belongs to the family Astraceae includes
approximately 100 species worldwide (Chaudhary, 2000) and
is widely distributed around the Mediterranean. Genus Card-
uus is presented in Saudi Arabia by two speciesCarduus pycno-
cephalus and C. arabicus, they are widely spread in central,
eastern and the northern regions of Saudi Arabia (Mandaville,
1990). In Chinese folk medicine, the plants of genus Carduusare used for the treatment of various human diseases such as
cold, stomach ache as well as rheumatism (Esmaeili et al.,
2005). Genus Carduus was found to possess a wide range of
biological activities such as liver tonicity, anti-inﬂammatory,
antispasmodic, anticancer, antiviral and antibacterial (Esmae-
ili et al., 2005; Jordon-Thaden and Louda, 2003; Frydman and
Deulofeu, 1962; Orhan et al., 2009). Phytochemical studies on
several Carduus species were carried out and revealed the pres-
ence of several classes of chemical constituents as lignans (Fer-
nandez et al., 1991), ﬂavonoids (Jordon-Thaden and Louda,
2003; El-Lakany et al., 1995,1997; Amer et al., 1985; Kaloshina
and Mazulin, 1998; Abdallah et al., 1989; Bain and Desro-
chers,1988; Abdel-Salam et al., 1982), Coumarin (Jordon-Tha-
den and Louda, 2003; Cardona et al., 1992), alkaloids
(Frydman and deulofeu, 1962), sterols and triterpenes (Ab-
del-Salam et al., 1982,1983). Concerning the phytoconstituents
of C. pycnocephalus L., the literature surveys revealed the pres-
ence of ﬂavonoids (El-Lakany et al., 1995, 1997; Amer et al.,
1985), essential oils (Esmaeili et al., 2005), sterols and triter-
Phytochemical and biological studies of Carduus pycnocephalus L. 411penes (Gallo and Sarachine, 2009). The present study deals
with the isolation and identiﬁcation of the main constituents
of the aerial parts of C. pycnocephalus growing in Saudi Ara-
bia. In addition, the study of the anti-inﬂammatory, antispas-
modic and hypotensive activities was performed.2. Material and methods
2.1. General experimental procedure
Melting points were determined on a Mettler FP 80 Central
Processor supplied with a Mettler FP 81 MBC Cell Apparatus,
and were uncorrected. Infra spectra were generally obtained in
potassium bromide pellets unless otherwise speciﬁed using Per-
kin–Elmer FTIR model 1600 spectrophotometer, USA. 1H
and 13C NMR spectra were recorded in CDCl3, CD3OD and
DMSO-d6 on a Bruker Avance DRX-500 instrument (Central
Lab. at the College of Pharmacy, KSU) at 500 MHz for pro-
tons and 125 MHz for carbons using the residual solvent signal
as an internal standard. All 1D and 2D spectra were obtained
using the standard Bruker software.; EI and FAB mass spectra
on a Jeol JMS, Ax 500, 5890 series II (Tokyo, Japan), ESI-MS
is carried out using a Finnigan LCQ-DECA mass spectrometer
connected to UV detector; Ultraviolet spectra obtained in
methanol using the shifting reagents AlCl3, NaOAc, NaOMe,
H3BO3 for ﬂavonoids were obtained using a Hewlett–Packard
HP-845 UV–Vis spectrophotometer. The ultraviolet lamp used
in visualizing TLC plates was a Mineralight device, multi-
band UV –254/366 nm obtained from UVP, Inc., USA. Col-
umn chromatography was performed on silica gel (60–230
mesh, Merck) and TLC was carried out with silica gel 60
pre-coated plates F-254 (Merck).
2.2. Plant material
The fresh plant was collected from Al-Hada (Saudi Arabia) on
March, 2008 and was kindly identiﬁed by Dr. Jakob Thomas,
College of science, KSU. A voucher specimen (#15106) was
deposited at the herbarium in the College of Pharmacy at
the King Saud University (KSU).
2.3. Phytochemical screening
Powdered samples of the aerial parts of C. pycnocephalus were
subjected to preliminary phytochemical screening (Evans, 2002).
2.4. Extraction
The ethanol extract (210.9 g) was obtained from the air dried
aerial parts of C. pycnocephalus (2.85 kg). It was re-suspended
in methanol:water (1:9) and extracted with petroleum ether
(40–60 C), chloroform, ethyl acetate and water saturated
butanol, each (0.5 L · 3), to give petroleum ether (47.3 g),
chloroform (23.5 g), ethyl acetate (8.9 g), butanol (19.2 g)
and aqueous (100 g) extracts.
2.5. Isolation of compounds 1–10
Part of the chloroform extract (13.5 g) was loaded on a silica
gel column (300 g) elution was started with hexane/chloroform
and the polarity increased with chloroform followed by meth-anol, 50 fractions, 200 ml each, were collected and the impor-
tant fraction was subjected to preparative thin layer
chromatography using 5% methanol in chloroform to give
compound 1 (8 mg). The ethyl acetate layer (8.9 g) was frac-
tionated by silica gel column chromatography (200 g) and
eluted with hexane/ethyl acetate (1:1) increasing the polarity
to reach 100% ethyl acetate then with methanol, ninety frac-
tions were collected (200 ml each). The main fractions were
re-chromatographed on silica gel column using the above sol-
vents, then followed by crystallization to give compound 4
(20 mg) from fraction 28 and compounds 2 (10 mg), 3
(26 mg), 7 (20 mg) from fractions 30–35. Chromatographic
analysis of a part of the butanol extract (10.5 g) on silica gel
column (150 g) using ethyl acetate/methanol as eluant gave
compounds 5 (16 mg) and 6 (16 mg). The petroleum ether ex-
tract (100 gm) was subjected to silica gel column (500 g) using
hexane as eluent and increasing the polarity with chloroform
till 100% chloroform, 60 fractions were collected (250 ml
each), the important fractions were re-chromatographed using
silica gel column (60 g) eluted with hexane then increasing the
polarity by using chloroform to give compounds 8 (6 mg), 9
(8 mg) and 10 (6 mg). The structures of the isolated com-
pounds were established by UV, IR, MS, 1D and 2D NMR,
as well as comparison with the published data.
2.5.1. Apigenin (1)
Eight milligrams were obtained as pale yellow powder, mp
343–345 C; Rf value 0.45 [CHCl3:MeOH, 9:1]; UV kmax;
MeOH: (nm) 266, 338; (NaOMe): 275, 320 sh., 393; (AlCl3):
275, 304 sh., 352, 383; (AlCl3/HCl): 276, 303 sh., 350, 383;
(NaOAc): 274, 301 sh., 378; (NaOAc/H3BO3): 266, 339.
1H
NMR (500 MHz, DMSO-d6, TMS) d (ppm) 7.80 (2H, d,
J= 8.0, H-20 and 60), 6.85 (2H, d, J= 8.0, H-30 and 50),
6.40 (1H, s, H-3), 6.05 (1H, s, H-8), 5.75 (1H, s, H-6), negative
ESI-MS m/z 269 [M+-H] for C15H10O5.
2.5.2. Kaempferol-3-O-b-D-glucopyranoside (2)
Ten milligrams of yellow powder, mp 228 C; Rf value; 0.60
[EtOAc:MeOH:Water, 30:5:4]; UV kmax; MeOH: (nm) 266,
351; (NaOMe): 275, 327 sh., 399; (AlCl3): 274, 304 sh., 352,
397; (AlCl3/HCl): 273, 303 sh., 342, 393 sh; (NaOAc): 274,
315 sh., 390; (NaOAc/H3BO3): 266, 351;
1H NMR (500,
DMSO-d6, TMS) d (ppm) 10.90 (1H, br s, OH-5), 6.22 (1H,
s, H-6), 12.63 (1H, s, OH-7), 10.20 (1H, br s, OH-40), 8.10
(1H, d, J= 8.0, H-20, 60), 6.90 (1H, d, J= 8.0, H-30, 50),
6.45 (1H, s, H-8), 5.47 (1H, d, J= 7.0, glucosyl H-100), 3–4
(4H, m, glucosyl protons) and 13C NMR (125 MHz, DMSO-
d6 TMS) d (ppm) 156.3 (C-2), 133.1 (C-3), 177.4 (C-4), 161.2
(C-5), 98.7 (C-6), 164.1 (C-7), 93.6 (C-8), 156.2 (C-9), 103.9
(C-10), 120.9 (C-10), 130.9 (C-20, 60), 115.1 (C-30, 50), 159.9
(C-40), 100.8 (C-100), 74.2 (C-200), 76.4 (C-300), 69.8 (C-400), 77.5
(C-500), 60.8 (C-600); FAB-MS (Positive ion) m/z 449
[M++H] for C21H20O11, 287 [M
+-glu + H].
2.5.3. Kaempferol-3-O-a-L-rhamnopyranoside (3)
Twenty-six milligrams of yellow residue, Rf value 0.65
[EtOAc:CH3OH:H2O, 30:5:4]; UV kmax; MeOH: (nm) 265,
351; (NaOMe): 273, 324 sh., 388; (AlCl3): 273, 303 sh., 348,
397 sh; (AlCl3/HCl): 275, 300 sh., 347, 396 sh.; (NaOAc):
273, 379; (NaOAc/H3BO3): 273, 342.
1H NMR (500 MHz,
CD3OD, TMS) d (ppm) 7.79 (1H, d, J= 8.0, H-20, 60), 6.96
(1H, d, J= 8.0, H-30, 50), 6.22 (1H, s, H-6), 6.39 (1H, s, H-
412 L.A. Al-Shammari et al.8), 5.40 (1H, s, rhamnosyl H-100), 3–4 (4H, m, rhamnosyl pro-
tons) and 13C NMR (125 MHz, CD3OD, TMS) d (ppm) 158.6
(C-2), 136.2 (C-3), 179.6 (C-4), 161.6 (C-5), 99.8 (C-6), 165.8
(C-7), 94.8 (C-8), 159.3 (C-9), 105.9 (C-10), 122.6 (C-10),
132.2 (C-20, 60), 116.5 (C-30, 50), 163.2 (C-40), 103.5 (C-100),
72.0 (C-200), 72.1 (C-300), 73.2 (C-400), 71.9 (C-500), 17.7 (C-600);
FAB-MS (Positive ion) m/z 433 [M++H] for C21H20O10,
287 [M+-rha + H].
2.5.4. Kaempferol-7-methoxy-3-O-a-L-rhamnopyranoside (4)
Twenty milligrams of yellow amorphous powder, Rf value 0.70
[EtOAc:CH3OH:H2O, 30:5:4];
1H NMR (500 MHz, CD3OD,
TMS) d (ppm) 7.79 (1H, d, J= 8.0, H-20, 60), 6.97 (1H, d,
J= 8.0, H-30, 50), 6.40 (1H, s, H-8), 6.22 (1H, s, H-6), 5.40
(1H, s, rhamnosyl H-100), 3.74 (3H, s, OCH3), 3–4 (4H, m,
rhamnosyl protons). 13C NMR (125 MHz, CD3OD, TMS) d
(ppm) 158.5 (C-2), 136.2 (C-3), 179.6 (C-4), 163.2 (C-5), 99.9
(C-6), 167.8 (C-7), 57.0 (OCH3), 94.8 (C-8), 159.3 (C-9),
105.9 (C-10), 122.6 (C-10), 131.9 (C-20, 60), 116.5 (C-30, 50),
161.6 (C-40), 103.5 (C-100), 72.0 (C-200), 71.9 (C-300), 73.2 (C-
400), 72.1 (C-500), 17.6 (C-600); FAB-MS (Positive ion) m/z 447
[M++H] for C22H22O10, 301 [M
+-rha].
2.5.5. Diosmetin-7-O-b-D-xylosyl-(1000ﬁ600)-b-D-
glucopyranoside (5)
Sixteen milligrams of yellow residue, 1H NMR (500 MHz,
DMSO-d6, TMS) d (ppm) 7.62 (1H, dd, J= 2.0, 8.4, H-60),
7.48 (1H,d, J= 2.4, H-20), 7.14 (1H, d, J= 8.8, H-50), 6.84
(1H, s, H-3), 6.83 (1H, d, J= 2.0, H-8), 6.46 (1H, d,
J= 2.0, H-6), 5.11 (1H, d, J= 7.2, glucosyl H-100), 4.17
(1H, d, J= 7.8, xylosyl H-1000), 3.87 (3H, s, OCH3-40), 3.65,
3.95 (2H, m, glucosyl CH2), 2.98, 3.70 (2H, m, xylosyl CH2),
3–4 (7H, m, remaining sugars protons), and 13C NMR
(125 MHz, DMSO-d6, TMS) d (ppm) 163.4 (C-2), 104.3 (C-
3, 182.5 (C-4), 161.6 (C-5), 100.1 (C-6), 164.7 (C-7), 95.3 (C-
8), 157.5 (C-9), 105.9 (C-10), 123.4 (C-10), 113.7 (C-20), 147.3
(C-30), 151.8 (C-40), 55.8 (OCH3-40), 112.7 (C-50), 119.4 (C-
60), 100.4 (C-100), 73.5 (C-200), 76.7 (C-300), 69.9 (C-400), 76.1
(C-500), 68.1 (C-600). 103.3 (C-1000), 73.9 (C-2000),76.0 (C-3000),
69.6 (C-4000), 66.1 (C-5000); ESI-MS (Positive ion) m/z 595
[M++H] for C27H30O15, 301 [M
+-glu-xyl+H].
2.5.6. Diosmetin-7-O-a-L-arabinosyl (1’’’ﬁ 6’’) -b-D-
glucopyranoside (6)
Sixteen milligrams of yellow residue, mp 187–188 C; Rf 0.62
[butanol:acetic acid:water, 24:10:1]; UV kmax; MeOH: (nm)
253, 269 sh., 344; (NaOMe): 253, 269 sh., 382; (AlCl3): 268,
300 sh., 357 sh., 388; (AlCl3/HCl): 274, 297 sh., 354.; (NaOAc):
269 sh., 355 (NaOAc/H3BO3): 269 sh., 346.
1H NMR
(500 MHz, DMSO-d6, TMS) d (ppm) 7.58 (1H, dd, 2.0, 8.8,
H-60), 7.46 (1H, d, 2.0, H-20), 7.16 (1H, d, 8.8, H-50), 6.84
(1H, s, H-3), 6.81 (1H, d, 2.0, H-8), 6.48 (1H, d, 2.0, H-6),
5.06 (1H, d, J= 7.2, glucosyl H-100), 3.87 (3H, s, OCH3-40),
4.15 (1H, d, J= 4.8, arabinosyl H-1000), 3.65, 3.95 (2H, m, glu-
cosyl CH2), 3.30, 3.65 (2H, m, arabinosyl CH2), 3–4 (7H, m,
remaining sugars protons). 13C NMR (125 MHz, DMSO-d6,
TMS) d (ppm) 164.7 (C-2), 104.3 (C-3, 182.5 (C-4), 161.6 (C-
5), 100.1 (C-6), 163.4 (C-7), 95.3 (C-8), 157.5 (C-9), 105.9 (C-
10), 123.4 (C-10), 113.7 (C-20), 147.3 (C-30), 151.8 (C-40), 55.8
(OCH3-4
0), 112.7 (C-50), 119.4 (C-60), 100.4 (C-100), 73.5 (C-
200), 76.7 (C-300), 69.9 (C-400), 76.1 (C-500), 68.1 (C-600). 103.3
(C-1000), 70.9 (C-2000), 72.9 (C-3000), 67.6 (C-4000), 65.1 (C-5000);FAB-MS (Positive ion) m/z 633 [M++K] for C27H30O15,
595 [M++H], 463 [M+-arab+H], 301 [M+-glu-arab+H].
2.5.7. Kaempferol-3-O-a-L-rhamnopyranosyl (1000ﬁ200) a-L-
rhamnopyranoside (7)
Twenty milligrams of yellow residue, mp 194–195; Rf value
0.13 [CHCl3:MeOH, 9:1]; UV kmax; MeOH: (nm) 265, 343;
(NaOMe): 253, 269 sh., 382; (AlCl3): 273, 303 sh., 348, 397
sh; (AlCl3/HCl): 274, 297 sh., 354, 395; (NaOAc): 271, 384;
(NaOAc/H3BO3): 265, 349.
1H NMR (500 MHz, MeOD,
TMS): d (ppm) 7.80 (2H, d, J = 8.5, H-20, 60), 6.97 (2H, d,
J = 8.5, H-30, 50), 6.41 (1H, s, H-8), 6.23 (1H, s, H-6), 5.40
(1H, br s, rhamnosyl H-100), 4.24 (1H, br s, rhamnosyl H-
1000), 3.88 (3H, s, OCH3-40), 3–4 (8H, m, thamnosyl protons),
1.31 (3H, d, J = 6, rhamnosyl CH3-6
00), 0.94 (3H, d, J = 6,
rhamnosyl CH3-6
000). 13C NMR (125 MHz, MeOD, TMS): d
(ppm) 158.6 (C-2), 136.8 (C-3, 179.6 (C-4), 163.0 (C-5), 99.9
(C-6), 166.0 (C-7), 94.8 (C-8), 159.3 (C-9), 105.5 (C-10),
123.0 (C-10), 131.9 (C-20), 116.5 (C-30), 161.6 (C-40), 116.5(C-
50), 131.9 (C-60), 101.0 (C-100), 78.0 (C-200), 71.9 (C-300), 73.2
(C-400), 72.0 (C-500), 17.7 (C-600). 103.5 (C-1000), 71.9 (C-2000),
72.1 (C-3000), 73.2 (C-4000), 72.0 (C-5000), 17.7 (C-6000); FAB-MS
(Positive ion) m/z 579 [M++H] for C27H30O14, 433 [M-
rha+H], 287 [M+-2 rha+H].
2.5.8. Lupeol (8)
Six milligrams of white powder, mp 211 C; FTIR (KBr) 3230,
1640, 1382, 1180,1105 cm1; UV kmax (MeOH) 201 nm;
1H
NMR (500 MHz, CDCl3): d 4.67, 4.56 (each 1H, m, H-29),
3.18 (1H, m, H-3), 1.69 (3H, s, H-30), 1.04 (3H, s, H-26, 0.98
(3H, s, H-23), 0.97 (3H, s, H-27), 0.84, 0.79 and 0.77 (each
3H, s, H-25, 28, 24); 13C NMR (125 MHz, CDCl3): d (ppm)
150.5 (C-20), 109.3 (C-6), 78.7 (C-3), 55.0 (C-5), 50.5 (C-9),
48.2 (C-18), 47.8 (C-19), 42.7 (C-17), 42.3 (C-14) 40.8 (C-8)
39.9 (C-22), 38.5 (C-4), 38.5 (C-1), 38.0 (C-13), 37.0 (C-10),
35.3 (C-16), 34.2 (C-7), 29.8 (C-21), 27.5 (C-23), 27.4 (C-15),
27.1 (C-2), 25.0 (C-12), 20.9 (C-11), 19.2 (C-30), 18.4 (C-6),
17.8 (C-28), 16.3 (C-25), 15.8 (C-26), 15.3 (C-24), 14.3 (C-
27); EI MS m/z 426 [M]+.
2.5.9. b-Sitosterol (9)
Eight milligrams of white powder, mp 136–138 C; FTIR
(KBr) 4330 cm1 (OH), 1050 cm1 (C–O), 2900, cm1 (for
C–H), 1430 cm1 (C‚C); 1H NMR (500 MHz, CDCl3): d
(ppm) 5.38 (br s, H-6), 3.50 (1H, m, H-3), 0.99 (3H, s, H-
19), 0.85 (3H, d, J = 7.5 Hz, H-26), 0.83 (3H, d, J= 7.5 Hz
H-27), 0.81 (3H, t, J= 7.5 Hz, H-29), 0.66 (3H, s, H-18);
13C NMR (125 MHz, CDCl3): d (ppm) 140.5 (C-5), 121.8
(C-6), 71.9 (C-3), 56.8 (C-14), 56.1 (C-17), 50.2 (C-9), 45.8
(C-24), 42.4 (C-13), 42.4 (C-4) 39.8 (C-12) 37.3 (C-1), 36.3
(C-10), 36.5 (C-20), 34.0 (C-22), 31.9 (C-7, 8), 31.7 (C-2),
29.2 (C-25), 28.3 (C-16), 26.1 (C-23), 24.4 (C-15), 23.1 (C-
28), 21.2 (C-11), 19.9 (C-27), 19.4 (C-26), 19.1 (C-19),18.8
(C-21), 12.0 (C-18), 11.9 (C-29); EI MS m/z 414 [M]+ for
C29H50O.
2.5.10. b-Sitosterol-3-O-b-D-glucoside (10)
(MeOH, 6 mg) white crystals, mp 289–290 C; {Rf; 0.31 (4%
methanol in chloroform}; FTIR (KBr) 3500–3200 cm1
(OH), 1026 cm1 (C–O), 2920, 2820 cm1 (for C–H),
1460 cm1(C‚C); UV kmax (CHCl3) 240 nm;
1H NMR
(500 MHz, DMSO-d6): d (ppm) 5.38 (br s, H-6), 4.26 (1H, d,
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1.05 (3H, s, H-19), 0.86 (6H, d, J= 7.5 Hz, H-26, H-27),
0.85 (3H, t, J= 7.5 Hz, H-29), 0.71 (3H, s, H-18); 13C NMR
(125 MHz, DMSO-d6): d (ppm) 140.5 (C-5), 121.1 (C-6), 76.9
(C-3), 56.2 (C-14), 55.4 (C-17), 49.6 (C-9), 45.2 (C-24), 41.8
(C-13), 40.1 (C-4) 39.4 (C-12) 38.8 (C-1), 36.2 (C-10), 35.5
(C-20), 33.4 (C-22), 31.4 (C-7, 8), 29.3 (C-2), 28.8 (C-16, 25),
27.7 (C-23), 25.6 (C-15), 23.8 (C-28), 22.6 (C-11), 20.3 (C-
27), 18.9 (C-26), 19.7 (C-19),19.1 (C-21), 11.8 (C-18), 11.6
(C-29), 100.8 (C-10), 76.8 (C-30), 76.7 (C-50), 73.5 (C-50), 70.1
(C-40), 61.1 (C-60); EI MS m/z 576 [M]+ for C35H60O6, 414
[M+-glucose].
2.6. Acid hydrolysis of compounds 2–7
Few milligrams of each compound was separately dissolved in
5 ml MeOH to which an equal volume of 10% sulphuric acid
was added. The mixture was reﬂuxed in a boiling water bath
for 3 h, and then cooled. The hydrolysate was shaken with
ethyl acetate (3 · 50 ml). The combined extract was distilled
off and subjected to TLC; the acidic mother liquor containing
the sugar moiety (s) was neutralized with sodium carbonate,
concentrated and separately spotted alongside authentic sugars
using chloroform:methanol (6:4) as solvent system and anisal-
dehyde sulphuric as spraying reagent.
2.7. Animals
Male Wistar rats weighing (100 g body weight each) were used
for anti-inﬂammatory and hypotensive activities. White male
New Zealand rabbits (2.5 kg) were killed and pieces of the jeju-
num were used to study the antispasmodic activity.
2.8. Biological studies
2.8.1. Anti-inﬂammatory activity (Ibrahim et al., 2011; Winter
et al., 1962)
Male Wistar rats weighing (100 g body weight each) were di-
vided into eight groups (three rats each). Group (a) serves as
negative control saline, group (b) alcohol extract, group (c)
petroleum ether extract, group (d) acetonitrile extract, group
(e) dichloromethane extract, group (f) ethyl acetate extract,
group (g) butanol extract and group (h) aqueous extract. Rat
paw oedema as a model of acute inﬂammation was induced
using formalin, modiﬁcation of Winter et al. (1962); a dose
of 0.1 ml of 10% formalin was injected into the paw of each
rat of eight groups. The animals will be treated with the sus-
pension of these fractions 500 mg/kg in 0.25% sodium carboxy
methyl cellulose 1 h before formalin injection via intraperito-
neal route. Oedema is induced by injecting formalin solution
into the rat hind paws.
The volume of the rat paw is measured in volume prior
to formalin injection and then two hours afterwards using
a Hydro-Plethysmometer (Model 7150, Ugo, Basile, Haly).
The rats were held ﬁrmly and the right paw will be im-
mersed into the pool of mercury up to the tibiotarsic artic-
ulation. The pressure increase due to the slight rise in
mercury level is transmitted to the pressure transducer. After
ampliﬁcation the transduced signal is increased as a deﬂec-
tion in the pen on the chart. The results expressed as% inhi-
bition of oedema were then calculated.2.8.2. Spasmolytic activity (El-Tahir et al., 1987; Bakheet et al.,
1999)
White male New Zealand rabbits (2.5 kg) were killed and
pieces of the jejunum (2.5 cm long) were cut and suspended
in oxygenated Kerb’s solution at 37 C as described by El-Ta-
hir et al. (1987). To test the effect of the different extracts on
the spontaneously contracting jejunum, different volumes of
suspended extract were added individually to the tissue and al-
lowed to contact it for 4 min to record any effect. Then after
the extract was washed out and the tissue was allowed rest
for 10 min another dose was tested. Each tissue was used to
test one extract only.
2.8.3. Hypotensive activity (El-Tahir and Al-Bekairi, 2003)
The male Wistar rats were kept in a room with 12 h dark and
12 h light cycles. Water and food were provided ad libitum.
The rats were anesthetized using 25% (w/v) aqueous urethane
at a dose of 1.25 g/kg b. wt. I.P. The carotid artery was cann-
ulated and connected to an ITT blood pressure transducer for
measurement of the arterial blood pressure. The heart rate was
calculated from the blood pressure pulse by increasing the rate
recording from 0.05 to 1 cm s1 in the Narco Physiograph
Coupler. All tested extracts in a dose of 30 mg/kg b. wt. were
injected intraperitoneally. The changes in blood pressure were
quantiﬁed in mm Hg using the calibration system built-in the
physiograph. The changes in the heart rate were calculated
as percentage change compared with the pre-drug level.
3. Results and discussion
3.1. Phytochemical screening
Preliminary phytochemical screening of the plant revealed the
presence of carbohydrates and/or glycosides, sterols and/or tri-
terpenes, alkaloids, ﬂavonoids, tannins and cardiac glycosides.
3.2. Characterisation of the isolated compounds
Petroleum ether, chloroform, ethyl acetate and butanol ex-
tracts of air dried aerial parts of C. pycnocephalus L. were sub-
jected to chromatographic separation followed by puriﬁcation
and gave 10 pure compounds 1–10 (Fig. 1). The identiﬁcation
of those compounds was carried out on the basis of spectro-
scopic methods (UV, IR, 1H NMR, 13C NMR, COSY,
HMBC, HSQC and MS).
Compound 1 was isolated from chloroform extract, it was
identiﬁed as apigenin by comparison of its UV, negative
ESI-MS and 1H NMR data with the literatures (Mabry et al.,
1970; Al-Gaber, 2011).
Compounds 2 and 3 were isolated from ethyl acetate ex-
tract. Analysis of their UV spectral data showed these com-
pounds to be 3 substituted ﬂavonol with free hydroxyl
groups at C-5, C-7 and C-40. Comparison of UV spectra in
methanol and shifting reagents, FAB-MS, 1H NMR and 13C
NMR spectral data of compounds 2 and 3 with reports (Has-
san et al., 2011; Markham et al., 1978, El-Youssef et al., 2008)
conﬁrmed that they were kaempferol-3-O-b-D-glucoside and
kaempferol-3-O-a-L-rhamnoside, respectively.
Compound 4 was isolated from ethyl acetate extract, UV,
1H, 13C NMR data were closely related to those of compound
3 except the presence of extra 1H NMR signals at dH 3.74 (3H,
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Figure 1 Structures of compounds isolated from Carduus pycnocephalus L.
414 L.A. Al-Shammari et al.s), for the methoxy group connected via HSQC to carbon at dC
57.0. The location of this methoxy group was evidenced from
the HMBC correlation of the proton signal at dH 3.74 with C-7
at dC 167.8. From the above data compound 4 was suggested
to be 7-methoxy derivative of 3, this was conﬁrmed from the
FAB-MS as it showed molecular ion peak at m/z 447
[M++H] with 14 mass unit difference from compound 3, in
addition to fragments at m/z 433 [M+-Me+H] and 287
[M+-Me-rha+H]. Thus compound 4 was identiﬁed as
kaempferol-7-methoxy-3-O-a-L-rhamnoside.
Compound 5 was isolated from the butanol extract. It was
identiﬁed as diosmetin-7-O-b-D-xylosyl-(1000ﬁ600)-b-Dglucoside
by comparing its spectral data [MS, 1D (1H NMR, 13C
NMR, and DEPT) and 2D (HMBC, HSQC, and COSY)
NMR] with values reported in the literature (Saeidnia et al.,2011; Park et al., 2009). This is the ﬁrst isolation of compound
5 from the genus Carduus.
Compound 6 was isolated from the butanol extract. Total
acid hydrolysis, UV, 1H NMR, 13C NMR, HSQC, HMBC,
COSY and FAB-MS were consistent with the literature data
(Mabry et al., 1970; Garaev et al., 2008). Thus compound 6
was identiﬁed as diosmetin-7-O-a-L-arabinosyl-(1000-600)-b-
Dglucopyranoside or palustroside. This compound was previ-
ously isolated from C. pycnocephalus (EL-Lakany et al.,
1995, 1997).
Compound 7 was isolated from ethyl acetate extract. The
FAB-MS, UV, 1H, 13C NMR data of compound 7 were in a
good agreement with those reported for kaempferol-3-O-a-L-
rhamnosyl-(1000-200)-a-L rhamnoside (Mabry et al., 1970; Rao
et al., 1998). This is the ﬁrst report for the isolation and
Table 2 % Inhibition of spontaneously contracting rabbit
jejunum by different extracts of Carduus pycnocephalus L. at
different doses.
Extract Dose mg/ml of tissue bath ﬂuid
(Tyrode’s solution)
1 10 15
Alcohol n.a. 50 ± 10.0 58 ± 20.9
Petroleum ether n.a. 11.9 ± 1.98 23.8 ± 3.12
Acetonitrile n.a. 11.1 ± 2.54 55.5 ± 7.97
Chloroform n.a. 37.5 ± 3.8 n.t.
Ethyl acetate 85.7 ± 2.96 100 ± 0.0 n.t.
Butanol 54.0 ± 7.0 100 ± 0.0 n.t.
n.a.: not active; n.t. not tested.
Table 3 Hypotensive activity effect of different extracts on the
blood pressure and heart rate at a dose of 30 mg/kg I.P.
Extracts
(30 mg/kg b. wt.)
Decrease in blood
pressure (mmHg)
% Decrease in the
heart rate
Total alcohol 9.0 ± 1.15 11.1 ± 1.05
Petroleum ether 4.5 ± 0.76 9.6 ± 3.53
Acetonitrile 10.8 ± 1.40 7.6 ± 1.50
Chloroform 18.0 ± 3.05 22.2 ± 4.01
Ethyl acetate 15.3 ± 0.72 30.7 ± 4.68
Butanol 15.3 ± 1.35 52 ± 5.03
Aqueous 22.5 ± 2.61 67 ± 8.32
Phytochemical and biological studies of Carduus pycnocephalus L. 415identiﬁcation of this compound from the genus Carduus and
second time in nature; it was previously isolated from Cassia
hirsuta (Rao et al., 1998).
Compounds 8–10 were identiﬁed by comparison of their
IR, EI-MS and 1H NMR, 13C NMR data with the literatures
as lupeol (Ahmad and Rahman, 1994), b-sitosterol and b-sitos-
terol-3-O-b-D-glucoside (Good and Akihisa, 1997).
3.3. Biological activities
We tried to carry out the biological activities on the pure com-
pounds to detect which of these compounds are responsible for
these activities but we could not perform them due to the low
yields of the pure compounds which were just enough for spec-
tral analysis.
3.3.1. Anti-inﬂammatory
Chloroform, ethyl acetate, aqueous and butanol extracts
(500 mg/kg, I.P.) exhibited signiﬁcant anti-inﬂammatory activ-
ity in formalin induced oedema in 75.2%, 75.2%, 61.9% and
59.27% inhibition, respectively. It was also observed that the
total alcohol and petroleum ether extracts showed the least ef-
fect by 30% inhibition of inﬂammation after two hours. So we
can conclude that Carduus pycnocephalus L. possesses anti-
inﬂammatory activity. The results were cited in Table 1.
3.3.2. Antispasmodic activity
At a dose of 1 mg/ml, the ethyl acetate extract was most effec-
tive as an antispasmodic by 85.7% followed by butanol extract
by 54% whereas the other extracts did not produce any spas-
molytic effect. At a dose of 10 mg/ml, ethyl acetate and buta-
nol extracts showed signiﬁcant antispasmodic activity by
100% followed by alcohol extract, chloroform, petroleum
ether and acetonitrile extracts by 50%, 37.5%, 11.9% and
11.1%, respectively, when compared to the control group. In
addition, at a dose of 15 mg/ml, the alcohol extract showed
spasmolytic effect by 58% followed by acetonitrile extract by
55.5% whereas petroleum ether extract showed less potent
spasmolytic effect. On the other hand, the present study re-
vealed that the aqueous extract showed stimulant effect. It in-
duced contraction of the jejunum. At doses of 1, 2, and 3 mg/
ml, it increased the contraction by 25%, 66.6% and 83.3%,
respectively, this means that the aqueous extract contains sub-
stances that cause smooth muscle contraction which can be
used for the atony occurring after general anaesthesia. The re-
sults were cited in Table 2.Table 1 Anti-inﬂammatory effects of different extracts of C
Group (500 mg/kg, I.P.) Net volume of oedema in ml (
1 hour 2
Control (saline) 0.59 ± 0.002 1
Total alcohol extract 0.50 ± 0.00 0
Petroleum ether extract 0.59 ± 0.005 0
Acetonitrile extract 0.59 ± 0.003 0
Chloroform extract 0.43 ± 0.003 0
Ethyl acetate extract 0.24 ± 0.0008 0
Butanol extract 0.26 ± 0.002 0
Aqueous extract 0.45 ± 0.0002 0
P< 0.05.
SEM= standard error of mean.3.3.3. Hypotensive activity
The hypotensive activity of aqueous, chloroform, ethyl acetate
and butanol extracts of C. pycnocephalus L. showed a decrease
in the arterial blood pressure at a dose of 30 mg/kg by 22.5, 18,
15.3 and 15.3 mmHg, respectively, while acetonitrile, total
alcoholic and pet. ether extracts exhibited minor effect on
decreasing blood pressure at the dose of 30 mg/kg by 10.8,
9.0 and 4.5 mmHg, respectively, when compared to the control
group. Also, the percentage decrease in heart rate was more
pronounced in both aqueous and butanol extracts at a small
dose of 30 mg/kg by 67.0 and 52.0, respectively. The cardio-
depressant activity of ethyl acetate extract at a dose of
30 mg/kg showed a decrease in heart rate by 30.7 mmHg. On
the other hand, the chloroform extract decreased heart rate
by 22.2 at a dose of 30 mg/kg, while other extracts showed lit-
tle change in heart rate. Most of the cardio-depressant activityarduus pycnocephalus on formalin induced oedema.
M± SEM) % Of inhibition after
hours 1 hour 2 hours
.13 ± 0.23 – –
.79 ± 0.02 15.25 30
.79 ± 0.004 Zero 30
.67 ± 0.088 Zero 38
.28 ± 0.002 27.1 75.2
.28 ± 0.0008 59.3 75.2
.46 ± 0.015 55.9 59.27
.43 ± 0.007 23.6 61.9
416 L.A. Al-Shammari et al.seemed to be contained in both aqueous and butanol extracts
at a dose dependent manner. It would be evident from above
that both aqueous and butanol extracts of C. pycnocephalus
L. possess a marked potency for lowering the blood pressure
and heart rate in rats at a dose-dependent manner, indicating
that they possess a vasodilation action. The results were cited
in Table 3. C. acanthoides preparations have been reported to
possess hypotensive activity (Boidadzhiev, 1964).Acknowledgements
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